Christa G. Gadellaa‐van Hooijdonk

Targeted Next Generation Sequencing as a Reliable Diagnostic Assay for the Detection of Somatic Mutations in Tumours Using Minimal DNA Amounts from Formalin Fixed Paraffin Embedded Material

Wendy W.J. de Leng, Christa G. Gadellaa‐van Hooijdonk, Françoise A. S. Barendregt-Smouter et al. · PLoS ONE · 2016 · 88 citations · Full text

Implementation of a Multicenter Biobanking Collaboration for Next-Generation Sequencing-Based Biomarker Discovery Based on Fresh Frozen Pretreatment Tumor Tissue Biopsies

Sander Bins, Geert A. Cirkel, Christa G. Gadellaa‐van Hooijdonk et al. · The Oncologist · 2016 · 36 citations · Full text

Tumor Heterogeneity and Personalized Cancer Medicine: Are we Being Outnumbered?

Geert A. Cirkel, Christa G. Gadellaa‐van Hooijdonk, Marco J. Koudijs et al. · Future Oncology · 2014 · 28 citations

Engineering, Cancer Management, Pathology +17

Detailed imaging and genetic analysis reveal a secondary <scp><i>BRAF</i>^L</scp>^505H resistance mutation and extensive intrapatient heterogeneity in metastatic <i><scp>BRAF</scp></i> mutant melanoma patients treated with vemurafenib

Marlous Hoogstraat, Christa G. Gadellaa‐van Hooijdonk, Inge Ubink et al. · Pigment Cell & Melanoma Research · 2014 · 27 citations · Full text

Pathology, Tumor Biology, Tumor Heterogeneity +16

Impact of a vacuum cushion on intrafraction motion during online adaptive MR-guided SBRT for pelvic and para-aortic lymph node oligometastases

Anita M. Werensteijn-Honingh, Ina M. Jürgenliemk‐Schulz, Christa G. Gadellaa‐van Hooijdonk et al. · Radiotherapy and Oncology · 2020 · 14 citations · Full text